CrossrefInfokarte
Safety profile of sintilimab and establishment of a risk prediction model based on medical records of 337 cases
Int. Journal of Clinical Pharmacology and Therapeutics · 2026-10-01 · 64 (10) · 537-547
DOI: 10.5414/cp205009 ↗Abstract
Kein Abstract verfügbar.
EUVIMED